Zobrazeno 1 - 10 of 866 pro vyhledávání: '"Lichtin AE"'
1
Report
Implication of PIGA genotype on erythrocytes phenotype in Paroxysmal Nocturnal Hemoglobinuria.
Autor: Gurnari C; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.; Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Tor Vergata, Rome, Italy., Pagliuca S; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.; Université de Paris, Paris, France., Patel BJ; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Awada H; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Kongkiatkamon S; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Terkawi L; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Zawit M; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Corey S; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Lichtin AE; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Carraway HE; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Wahida A; Torsten-Haferlach Leukemia Diagnostics Foundation, Munich, Germany., Visconte V; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Translational Hematology and Oncology Research Department, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH, USA. maciejj@ccf.org.
Publikováno v: Leukemia [Leukemia] 2021 Aug; Vol. 35 (8), pp. 2431-2434. Date of Electronic Publication: 2021 Jan 22.
Zobrazit plný text záznamu
2
Report
Novel invariant features of Good syndrome.
Autor: Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Department of Biomedicine and Prevention, Phd in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy., Durrani J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Pagliuca S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Kishtagari A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Awada H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Kerr CM; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Adema V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Kongkiatkamon S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Lichtin AE; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA., Patel BJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA., Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA., Sekeres MA; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA., Cook JR; Department of Laboratory Medicine, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland, OH, USA. maciejj@ccf.org.; Leukemia Program, Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland, OH, USA. maciejj@ccf.org.
Publikováno v: Leukemia [Leukemia] 2021 Jun; Vol. 35 (6), pp. 1792-1796. Date of Electronic Publication: 2021 Jan 07.
Zobrazit plný text záznamu
3
Akademický článek
Frequency and perturbations of various peripheral blood cell populations before and after eculizumab treatment in paroxysmal nocturnal hemoglobinuria.
Autor: Gurnari C; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy. Electronic address: carmelogurnari31@gmail.com., Graham AC; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Efanov A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Pagliuca S; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; University Paris Diderot, Paris, France., Durrani J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Awada H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Patel BJ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Lichtin AE; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Sekeres MA; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Publikováno v: Blood cells, molecules & diseases [Blood Cells Mol Dis] 2021 Mar; Vol. 87, pp. 102528. Date of Electronic Publication: 2020 Dec 08.
Zobrazit plný text záznamu
4
Akademický článek
Large granular lymphocytic leukaemia after solid organ and haematopoietic stem cell transplantation.
Autor: Awada H; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Mahfouz RZ; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Durrani J; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Kishtagari A; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Jagadeesh D; Lymphoid Malignancies Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Lichtin AE; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Hill BT; Lymphoid Malignancies Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Hamilton BK; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Carraway HE; Leukaemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Nazha A; Leukaemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Majhail NS; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Sobecks R; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Visconte V; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Kalaycio M; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Sekeres MA; Leukaemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Maciejewski JP; Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
Publikováno v: British journal of haematology [Br J Haematol] 2020 Apr; Vol. 189 (2), pp. 318-322. Date of Electronic Publication: 2020 Jan 20.
Zobrazit plný text záznamu
5
Akademický článek
Immature reticulocyte fraction: A novel biomarker of hemodynamic severity in pulmonary arterial hypertension.
Autor: Brownstein, Adam J.1 (AUTHOR) abrownstein@mednet.ucla.edu, Wilkinson, Jared D.2 (AUTHOR), Liang, Lloyd L.1 (AUTHOR), Channick, Richard N.1 (AUTHOR), Saggar, Rajan1 (AUTHOR), Kim, Airie1 (AUTHOR)
Publikováno v: Pulmonary Circulation. Jul2024, Vol. 14 Issue 3, p1-16. 16p.
Zobrazit plný text záznamu
6
Akademický článek
Subclonal STAT3 mutations solidify clonal dominance.
Autor: Kerr CM; Department of Translational Hematology and Oncology Research and., Clemente MJ; Department of Translational Hematology and Oncology Research and., Chomczynski PW; Department of Translational Hematology and Oncology Research and., Przychodzen B; Department of Translational Hematology and Oncology Research and., Nagata Y; Department of Translational Hematology and Oncology Research and., Adema V; Department of Translational Hematology and Oncology Research and., Visconte V; Department of Translational Hematology and Oncology Research and., Lichtin AE; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Mustjoki S; Hematology Research Unit Helsinki, University of Helsinki, Helsinki, Finland.; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Centre, Helsinki, Finland; and., Radivoyevitch T; Quantitative Health Sciences Department, Cleveland Clinic, Cleveland, OH., Sekeres MA; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH., Maciejewski JP; Department of Translational Hematology and Oncology Research and.; Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH.
Publikováno v: Blood advances [Blood Adv] 2019 Mar 26; Vol. 3 (6), pp. 917-921.
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Thrombotic thrombocytopenic purpura: The role of ADAMTS13.
Autor: Rogers HJ; Medical Director of Hemostasis and Thrombosis, Hematopathologist, Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA. E-mail: rogersj5@ccf.org.; Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA., Allen C; Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA., Lichtin AE; Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic; Cleveland, OH, USA.; Associate Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.
Publikováno v: Cleveland Clinic journal of medicine [Cleve Clin J Med] 2016 Aug; Vol. 83 (8), pp. 597-603.
Zobrazit plný text záznamu
10
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje